Skip to main content

Reading your MRI report

Brain tumour MRI: what a “space-occupying lesion” report actually means (2026 UK guide)

If a brain MRI has come back with the phrase “space-occupying lesion”, “focal lesion” or “abnormal enhancement”, the words in the report are doing a lot of heavy lifting. Most of what looks like a tumour is not one, and MRI has become the standard first-and-final imaging for those that are. This is what the language on the report actually indicates.

By The Pulse Atlas Editorial Team

10 min read · 30 August 2026

A radiologist reviewing a brain MRI on a workstation
A neuro-radiologist reviewing a brain MRI on a reporting workstation. Illustrative image.

A brain MRI report can be terrifying to read at home, on a phone, on a Friday evening. The vocabulary is deliberately cautious, the phrasing is deliberately non-committal, and the words that stand out - lesion, mass, enhancement, oedema - are exactly the words a Google search treats as synonyms for cancer. Most of the time they are not. This piece is what those words actually mean in a UK radiology report in 2026, and what the follow-up pathway looks like when the report is genuinely concerning.

The one-line answer

A “space-occupying lesion” on a brain MRI simply means there is something on the scan that takes up space where normal brain tissue should be. It is a description, not a diagnosis. The lesion may be a cyst, a benign meningioma, a vascular malformation, an old injury, an area of inflammation, a metastasis or a primary tumour. Which of those it is depends on the pattern of signal, enhancement, location and mass effect, and on your clinical picture. The report should be read alongside a neurologist or neurosurgeon, not alone at midnight.

What a brain MRI actually looks at when hunting for a tumour

A modern UK brain MRI protocol for suspected tumour is not one image. It is a sequence of pulse settings that each highlight tissue differently, and the radiologist reads them together.

  • T1-weighted shows anatomy. Fat is bright, fluid is dark. Good for spatial orientation and picking out haemorrhage.
  • T2-weighted shows fluid as bright. Most tumours, oedema and cysts stand out here.
  • FLAIR is a T2 sequence with the cerebrospinal fluid signal removed, so lesions near the ventricles and cortex are much easier to see.
  • DWI (diffusion-weighted imaging) shows restricted movement of water molecules. Abscesses, acute stroke and some high-grade tumours restrict diffusion.
  • Post-contrast T1 is repeated after intravenous gadolinium. Areas where the blood-brain barrier is broken down (many tumours, metastases, abscesses, active MS plaques) light up.
  • MR spectroscopy and perfusion are sometimes added for characterising a lesion further - measuring metabolite peaks and blood flow to help differentiate tumour from mimic.

If any of these sequences is missing from a scan done to characterise a brain lesion, it is worth asking why. A brain-tumour work-up without contrast is almost always incomplete.

Reading the report vocabulary

UK radiology reports are written in a specific dialect. Here is what the phrases that tend to alarm patients actually mean.

  • Space-occupying lesion. A generic descriptor. Something is there that should not be. It does not indicate tumour vs cyst vs abscess on its own.
  • Mass effect. The lesion is pushing on surrounding brain, effacing sulci or compressing a ventricle. Present in tumours, but also in large cysts or big areas of oedema.
  • Midline shift. The septum between the two hemispheres has been pushed across from the midline. Significant midline shift is a neurosurgical concern regardless of cause.
  • Ring-enhancing. The lesion enhances around its edges but not in the middle, often because the centre is necrotic. Classic for high-grade glioma, metastasis, abscess and some demyelinating lesions.
  • Restricted diffusion. Water molecules are moving less freely inside the lesion. Suggests dense cellularity (some tumours), pus (abscess) or acute infarct.
  • Vasogenic oedema. Fluid leaking from damaged vessels into surrounding white matter, giving a finger-like bright signal on FLAIR around the lesion. Very common around tumours and metastases.
Phrase in the reportWhat it usually meansConcerning in isolation?
“Small T2 hyperintense focus”A tiny bright spot, often a chronic small-vessel changeUsually not
“Extra-axial lesion, avidly enhancing”Outside the brain tissue itself, likely meningiomaOften benign
“Ring-enhancing intra-axial lesion with oedema”Inside the brain, tumour, metastasis or abscessYes, needs urgent review
“Mass effect with midline shift”Large enough to displace normal structuresYes, neurosurgical
“Developmental venous anomaly”A normal variant vein patternNo

The common benign findings that are NOT tumours

A large fraction of “abnormal” brain MRIs describe things that are entirely benign, often incidental, and require no treatment at all. The most common are:

  • Arachnoid cyst. A pocket of cerebrospinal fluid trapped between the layers of the arachnoid membrane. Present from birth in many people, usually asymptomatic, only occasionally requiring drainage if very large.
  • Developmental venous anomaly (DVA). An unusual pattern of normal veins draining the brain. Looks striking on contrast imaging. Extremely common, essentially never causes symptoms on its own.
  • Small meningioma. A slow-growing tumour arising from the meninges, the covering of the brain. Very common incidental finding, particularly in women over 50. Small, asymptomatic ones are usually watched with follow-up MRIs.
  • Colloid cyst. A small cyst usually sitting in the third ventricle. Most are stable. A minority obstruct CSF flow and need neurosurgical review.
  • Choroid plexus cyst. Fluid within the choroid plexus, a tissue that produces cerebrospinal fluid. Essentially always benign in adults.

These findings routinely land in reports with the phrase “incidental finding, no clinical significance”, but that reassurance can be buried below more alarming descriptive lines. Reading the whole report, and not just the first sentence, matters.

The specific patterns that suggest tumour

Certain combinations of findings shift the probability meaningfully towards tumour rather than mimic. Radiologists talk about these as a “concerning constellation” rather than any single sign.

  • A ring-enhancing lesion with surrounding vasogenic oedema. The classic appearance of a high-grade glioma or metastasis. Abscess and demyelination can mimic this, so DWI and clinical history matter.
  • Mass effect out of proportion to lesion size. A small lesion producing lots of surrounding oedema and displacement suggests aggressive biology.
  • Irregular, thickened, nodular enhancement. Neat, thin, uniform enhancement is more likely benign. Chunky, irregular enhancement is more concerning.
  • Restricted diffusion within the enhancing component. Points towards dense cellularity, seen in higher-grade tumours and lymphoma.
  • Crossing the midline via the corpus callosum. The “butterfly” appearance is a classic sign of glioblastoma.

None of these are diagnostic on their own. A confident radiological diagnosis still requires either time (a follow-up scan showing behaviour) or tissue (a biopsy).

Primary tumours vs metastases on MRI

The other question the report is often quietly answering is whether this looks like a tumour that started in the brain, or one that spread there from elsewhere.

  • Single lesion, deep white matter, crossing midline. More typical of a primary brain tumour, particularly high-grade glioma.
  • Multiple round enhancing lesions at the grey-white junction. The signature pattern of brain metastases. Lung, breast, melanoma, kidney and colorectal are the commonest primaries in the UK.
  • Extra-axial mass with a dural tail. Meningioma, arising from the meninges rather than the brain itself. Usually benign.
  • Cerebellar or brainstem lesion in a child. Paediatric brain tumours (medulloblastoma, pilocytic astrocytoma, ependymoma) have their own patterns and are managed in specialist paediatric neuro-oncology centres.

If the pattern looks like metastases, the follow-up work-up almost always includes a CT of chest, abdomen and pelvis, and often a PET/CT, to hunt for the primary.

A patient entering an MRI scanner for a brain study
A patient entering the scanner for a contrast-enhanced brain MRI. Illustrative image.

The follow-up pathway after a suspicious MRI

If a brain MRI comes back with a lesion the radiologist thinks may be a tumour, there is a well-defined pathway in the UK, whether the scan was NHS or private.

  • Neurosurgical or neurology referral. The imaging and clinical picture are reviewed by a consultant, usually within days for a suspicious lesion. In the private sector this is often bookable inside a week.
  • Neuro-oncology MDT. The case is discussed by a multidisciplinary team - neurosurgeon, neuro-radiologist, oncologist, neuropathologist, specialist nurse. Every UK cancer centre runs one weekly.
  • Advanced imaging. If the diagnosis is uncertain, the MDT may request MR spectroscopy, MR perfusion or a PET/MRI to characterise the lesion further before deciding on biopsy.
  • Biopsy or resection. Definitive diagnosis requires tissue. This may be a stereotactic needle biopsy or, if surgery is likely to be needed anyway, a resection.
  • Neuropathology and molecular profiling. The tissue is examined and, in 2026, routinely tested for molecular markers (IDH, MGMT, 1p/19q) that determine grade and treatment.

Alongside this, patients are entitled to a subspecialist neuro-radiology second opinion on the imaging itself, which is often the single most useful thing to arrange privately. Reads can differ meaningfully, particularly for equivocal lesions.

How Pulse Atlas books a private brain MRI with expert review

If you want a private brain MRI in the UK - either as a first scan or a repeat with subspecialist review - the process through Pulse Atlas is deliberately short. You send us the referral, the symptoms, and any previous imaging. We come back within one working day with two or three imaging centres appropriate for the question, the all-in price up front (scan, contrast, subspecialist neuro-radiology report), and next available slots. If a consultant neurologist or neurosurgeon opinion is likely to be needed on the back of the scan, we shortlist those in parallel so the follow-up is not another wait.

For more detail on the underlying test, see our MRI overview and find-care hub.

Common questions

FAQs

Does “lesion” always mean tumour?

No. In radiology “lesion” simply means an area of tissue that looks different from the surrounding brain. That can be a cyst, a small vascular malformation, a patch of inflammation, an old injury or scar, or a tumour. Most incidentally-found brain lesions are not cancer.

What does “enhancement” mean on a brain MRI?

Enhancement means the lesion took up gadolinium contrast, which suggests a breakdown of the blood-brain barrier. Enhancement is common in high-grade tumours, metastases, abscesses and active demyelination. It is not by itself proof of cancer, but a new enhancing lesion always warrants specialist review.

How much does a private brain MRI cost in the UK in 2026?

All-in prices for a private brain MRI with contrast range from £450 to £850 outside central London, and £700 to £1,100 in central London. Reporting is usually included, subspecialist neuro-radiology review may cost £150 to £300 more.

Do I need contrast for a brain tumour MRI?

For any scan looking for or following up a suspected tumour, yes. Gadolinium contrast is what makes many tumours, metastases and post-treatment changes visible. A non-contrast brain MRI is fine for screening headache or ruling out stroke, but not for characterising a lesion.

Can an MRI tell benign from malignant?

Often it can strongly suggest one over the other, based on shape, enhancement, diffusion and location. But MRI cannot give a definitive tissue diagnosis. That still requires a biopsy or surgical sample reviewed by a neuropathologist.

How quickly can I get a private second opinion on a brain MRI?

A subspecialist neuro-radiology second read of an existing MRI can usually be arranged within 48 to 72 hours in the UK, at a cost of around £200 to £400. A consultant neurologist or neurosurgeon opinion is typically bookable within 3 to 7 days privately.

MRI vs CT for brain tumours - which is better?

MRI is the standard of care for detecting and characterising brain tumours. CT is faster and useful in emergencies (haemorrhage, acute trauma), but it is much less sensitive to smaller tumours, posterior fossa lesions and subtle enhancement patterns.

Written by

The Pulse Atlas Editorial Team

This is our editorial team, in charge of researching, editing and reviewing every blog we publish. Each piece is put together from the most recent public research on how the UK healthcare industry actually works in 2026 - private clinics, NHS wait times, insurer behaviour and patient experience.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

We reply to every enquiry within 24 hours (Mon–Fri). Confidential - your details are never shared outside our vetted consultant network.